Longevity Health Holdings Inc.
OTC: XAGE0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Janakiram Ajjarapu
- Employees
- 15
- Headquarters
- Pittsburgh, United States
- IPO year
- 2021
- Market cap
- $436.0K
- Website
- https://www.carmellcosmetics.com
Loading XAGE…
Loading profile data…Frequently asked questions about XAGE
What does Longevity Health Holdings Inc. (XAGE) do?
Longevity Health Holdings Inc. specializes in creating plasma-based bioactive materials (PBMs) aimed at fostering tissue regeneration and repair in response to injury, illness, and the natural aging process. The company's primary investigational product is CT-101, which acts as a powerful accelerant for bone healing in diverse applications such...
Where does XAGE trade?
Longevity Health Holdings Inc. (XAGE) trades on the Other OTC.
What sector is XAGE in?
Longevity Health Holdings Inc. (XAGE) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Longevity Health Holdings Inc.?
Janakiram Ajjarapu is the chief executive officer of Longevity Health Holdings Inc. (XAGE).
Where is Longevity Health Holdings Inc. headquartered?
Longevity Health Holdings Inc. is headquartered in United States.
Does XAGE pay a dividend?
Longevity Health Holdings Inc. (XAGE) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did XAGE go public?
Longevity Health Holdings Inc. (XAGE) completed its initial public offering in 2021.